Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization
Study Objective To estimate the impact of adherence to and persistence with atypical
antipsychotics on health care costs and risk of hospitalization by controlling potential …
antipsychotics on health care costs and risk of hospitalization by controlling potential …
Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications
IS Al-Zakwani, JJ Barron, MF Bullano… - … medical research and …, 2003 - Taylor & Francis
Objective: To examine the effects of typical and atypical antipsychotics on medication
adherence and healthcare resource utilization. Research design and methods: This was a …
adherence and healthcare resource utilization. Research design and methods: This was a …
Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
T Dilla, A Ciudad, M Alvarez - Patient preference and adherence, 2013 - Taylor & Francis
Purpose There is strong evidence supporting the link between nonadherence to
antipsychotic medication and relapse of schizophrenia. However, less obvious are the …
antipsychotic medication and relapse of schizophrenia. However, less obvious are the …
Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia
S Offord, J Lin, D Mirski, B Wong - Advances in therapy, 2013 - Springer
Introduction To quantify early nonadherence to antipsychotic medications in patients with
schizophrenia and its impact on short-term antipsychotic adherence, healthcare utilization …
schizophrenia and its impact on short-term antipsychotic adherence, healthcare utilization …
Patterns of adherence to oral atypical antipsychotics among patients diagnosed with schizophrenia
JP MacEwan, FM Forma, J Shafrin, A Hatch… - Journal of managed …, 2016 - jmcp.org
BACKGROUND: Poor medication adherence contributes to negative treatment response,
symptom relapse, and hospitalizations in schizophrenia. Many health plans use claims …
symptom relapse, and hospitalizations in schizophrenia. Many health plans use claims …
Rates and predictors of antipsychotic non-adherence and hospitalization in Medicaid and commercially-insured patients with schizophrenia
K Lang, V Federico, E Muser, J Menzin… - Journal of Medical …, 2013 - Taylor & Francis
Objective: To assess rates and predictors of antipsychotic non-adherence and
hospitalizations among patients with schizophrenia in separate Medicaid and commercial …
hospitalizations among patients with schizophrenia in separate Medicaid and commercial …
Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.
TB Gibson, Y Jing, E Kim, E Bagalman… - … care (Langhorne, Pa …, 2010 - europepmc.org
Cost-sharing effects on adherence and persistence for second-generation antipsychotics in
commercially insured patients. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
commercially insured patients. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics
D Pilon, M Alcusky, Y Xiao… - Journal of Medical …, 2018 - Taylor & Francis
Aims: This study compared healthcare resource utilization (HRU), healthcare costs,
adherence, and persistence among adult patients with schizophrenia using once-monthly …
adherence, and persistence among adult patients with schizophrenia using once-monthly …
Assessment of compliance with antipsychotic treatmentand resource utilization in a medicaid population
M Eaddy, A Grogg, J Locklear - Clinical Therapeutics, 2005 - Elsevier
BACKGROUND:: Partial compliance with mental healthmedications has been associated
with an increased risk of clinical worsening, relapse, and repeat hospitalization …
with an increased risk of clinical worsening, relapse, and repeat hospitalization …
Role of patient experience in atypical antipsychotic adherence: a retrospective data analysis
M Vanelli, M Coca-Perraillon, A Troxell-Dorgan - Clinical therapeutics, 2007 - Elsevier
Objective: We report on differences in atypical antipsychotic adherence after the start of
outpatient treatment with atypical antipsychotics in patients receiving routine clinical care …
outpatient treatment with atypical antipsychotics in patients receiving routine clinical care …